Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea
Dae Geon Ahn, Hyung Joon Kim, Hyun Kang, Hyun Woong Lee, Si Hyun Bae, Joon Hyoek Lee, Yong Han Paik, June Sung Lee
Korean J Intern Med. 2016;31(1):46-53.   Published online 2015 Dec 28     DOI: https://doi.org/10.3904/kjim.2016.31.1.46
Citations to this article as recorded by Crossref logo
Changes in serum α-fetoprotein level predicts treatment response and survival in hepatocellular carcinoma patients and literature review
Wen-Chi Chou, Chia-Lin Lee, Tsai-Sheng Yang, Chen-Yang Huang, Wei Teng, Ya-Ting Tseng, Jen-Shi Chen, Yung-Chang Lin, Ming-Mo Hou, Ho-Hsiang Chang, Jason Chia-Hsun Hsieh
Journal of the Formosan Medical Association.2018; 117(2): 153.     CrossRef
Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
Cha Young Kim, Bo Ra Kim, Sang Soo Lee, Dae-Hong Jeon, Chang Min Lee, Wan Soo Kim, Hyun Chin Cho, Jin Joo Kim, Jae Min Lee, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Woon Tae Jung, Ok-Jae Lee
Medicine.2017; 96(2): e5844.     CrossRef
A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma
Areum Sohn, Hyunsoo Kim, Su Jong Yu, Jung-Hwan Yoon, Youngsoo Kim
Analytical and Bioanalytical Chemistry.2017; 409(11): 2829.     CrossRef